Article
GLI2 inhibition abrogates human leukemia stem cell dormancy
21 Mar 2015
Abstract excerpt
BACKGROUND: Dormant leukemia stem cells (LSC) promote therapeutic resistance and leukemic progression as a result of unbridled activation of stem cell gene expression programs. Thus, we hypothesized that 1) deregulation of the hedgehog (Hh) stem cell self-renewal and cell cycle regulatory pathway would promote dormant human LSC generation and 2) that PF-04449913, a clinical antagonist of the GLI2 transcriptional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
